Supplementary Data from The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
Androgenetic alopecia global photographs pre- and post-treatment of with 5α-reductase inhibitors (5ARI). The images compared patients before and after 5ARI treatment. Patient 1(M/55): greatly increase
Supplementary materials for JAAD-D-20-01192R2 Treating toxic epidermal necrolysis with systemic immunomodulating therapies: a systematic review and network meta-analysis
Objective To assess over 3 years of follow-up, the effects of maintaining or switching to ocrelizumab (OCR) therapy on clinical and MRI outcomes and safety measures in the open-label extension (OLE)